Gano Kyle bought NBIX
February 12, 2026 · Form 4 insider transaction
Gano Kyle bought 4,907 shares of Neurocrine Biosciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
4,907
Price
$0.00
Total value
N/A
InsiderGano Kyle
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateFebruary 12, 2026
Filing dateFebruary 17, 2026
Shares owned after146,661
OwnershipDirect
10b5-1 planNo
AmendedNo